These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10201931)

  • 1. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor.
    Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N
    J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
    Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
    J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ; Oshima M
    Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH; Macklin KD; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
    Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
    J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
    Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
    J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.
    Wall KA; Hu JY; Currier P; Southwood S; Sette A; Infante AJ
    J Immunol; 1994 May; 152(9):4526-36. PubMed ID: 8157967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
    J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a.
    Hill M; Beeson D; Moss P; Jacobson L; Bond A; Corlett L; Newsom-Davis J; Vincent A; Willcox N
    Ann Neurol; 1999 Feb; 45(2):224-31. PubMed ID: 9989625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
    Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
    J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
    Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
    J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.
    Wu B; Deng C; Goluszko E; Christadoss P
    J Immunol; 1997 Sep; 159(6):3016-23. PubMed ID: 9300727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
    Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
    J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.